Caspian Oliai, MD, MS

home / authors / caspian-oliai-md-ms

Caspian Oliai, MD, MS, is a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center.

Articles

Red blood cells flowing realistically, 3D rendering: © Kodjovi - stock.adobe.com

May 1st 2025

Orca-T Shows Efficacy, Reduced GVHD Risk in Acute Leukemia, MDS

Caspian Oliai, MD, MS Mary Caffrey Rose McNulty

Orca-T shows promise to reduce rehospitalization and improve outcomes in MDS and acute leukemias.| Image credit: Eleni - stock.adobe.com

April 11th 2025

Reduced Rehospitalizations and Potential Cost Savings With Orca-T for Acute Leukemia, MDS: Caspian Oliai, MD, MS

Mary Caffrey Caspian Oliai, MD, MS Rose McNulty

Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.

Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center

April 2nd 2025

Orca-T Shows Efficacy, Reduced GVHD Risk in Acute Leukemia, MDS: Caspian Oliai, MD

Mary Caffrey Caspian Oliai, MD, MS

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses findings from the phase 3 Precision-T trial of Orca-T in acute leukemia and myelodysplastic syndrome (MDS).